Albanian epidemiologist: Studies show that the virus is more contagious, but it has lost its killer power

There are some studies that in recent weeks are showing that the SARS-CoV-2 virus, the source of pandemic that causes COVID-19, is performing several mutations that make it more aggressive in the process of infection, but with a less lethal power than at its beginnings. According to epidemiologist Ilir Alimehmeti, this is [...]
There are some studies that in recent weeks are showing that the SARS-CoV-2 virus, the source of pandemic that causes COVID-19, is performing several mutations that make it more aggressive in the process of infection, but with a less lethal power than at its beginnings.
According to epidemiologist Ilir Alimehmeti, this is natural and expected. It's like other viruses, when it first spreads into the population it starts to adapt, because if it's too deadly to wipe out the host, so a human will kill himself. It's simple logic followed by any virus. This process occurs in the first phase, then when natural protections are driven or through the vaccine viruses tend to make mutations, so there is no kind of wonder, we're just waiting for this” phase, says Alimehmet for A2.
In detail, the doctor tells of an American study. “The study shows that there has been a mutation in the G-614 format, the new form of the virus, which makes the domen associated with cellular receptors more exposed, something that makes it increase the possibility of transmission but also makes it more aggressive by antiquity, giving easier symptoms. This is an American study in Los Alamos, one of the best structural virology groups.
The news today came from Russia, where President Putin himself has declared that his country has developed a vaccine to the disease, and that one of his daughters had injected him.
Alimehmet seems somewhat skeptical, but not exclusive, at this point. It would be very good news if it were true, but there is no evidence published so far. It is their right to secretly experiment the first and second clinical stage, but the third phase, that clinical efficiency, seems not tested. The fact that someone's daughter has done a vaccine is not a scientific basis for others to do it”, he says.












